Barbara Merritt, in Afton, WY - Counselor

Barbara Merritt, is a Counselor - Mental Health based in Afton, Wyoming. Barbara Merritt is licensed to practice in Wyoming (license number WY-LCSW-936) and her current practice location is 389 Adams St, Afton, Wyoming. She can be reached at her office (for appointments etc.) via phone at (307) 885-9883.

NPI number for Barbara Merritt is 1679909725 and her current mailing address is Po Box 376, Afton, Wyoming. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1679909725.

Contact Information

	Barbara Merritt,
	389 Adams St, Afton, WY 83110
	(307) 885-9883
	(307) 885-5206

Healthcare Provider's Profile

Full Name	Barbara Merritt
Gender	Female
Speciality	Counselor - Mental Health
Location	389 Adams St, Afton, Wyoming
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1679909725
Provider Enumeration Date: 09/20/2013
Last Update Date: 11/19/2015

Medical Identifiers

Medical identifiers for Barbara Merritt such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1679909725	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	PCSW-546 (Wyoming)	Secondary
101YM0800X	Counselor - Mental Health	WY-LCSW-936 (Wyoming)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Barbara Merritt is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Barbara Merritt, Po Box 376, Afton, WY 83110-0376 Ph: (307) 885-9883	Barbara Merritt, 389 Adams St, Afton, WY 83110 Ph: (307) 885-9883

News Archive

Continuous positive airway pressure reduces cardiovascular mortality in elderly OSA patients

Continuous positive airway pressure (CPAP) effectively decreases the risk of cardiovascular death in elderly patients who suffer from obstructive sleep apnea (OSA), according to a study conducted by researchers in Spain.

Positive data from Celator's CPX-351 Phase 2 study in newly-diagnosed AML presented at 52nd ASH

Celator Pharmaceuticals today announced positive clinical data in elderly patients with newly-diagnosed acute myeloid leukemia (AML) treated with CPX-351 (Cytarabine:Daunorubicin) Liposome Injection. Data were presented from the podium at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, Florida.

Some Alzheimer's patients can benefit from drug Memantine

The drug memantine can reduce cognitive deterioration and loss of everyday functions in patients with moderate to severe Alzheimer's disease, according to a new review of studies.

First demonstration of COVID-19-like response by an essential virus encoded protein by SARS-CoV-2 in vivo

Researchers from collaborating universities in Virginia have recently utilized transgenic mice to explore the effects of SARS-CoV-2 on associated lung injury.

Barbara Merritt, - in Afton, WY